190 related articles for article (PubMed ID: 15596521)
1. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.
Dong T; Stewart-Jones G; Chen N; Easterbrook P; Xu X; Papagno L; Appay V; Weekes M; Conlon C; Spina C; Little S; Screaton G; van der Merwe A; Richman DD; McMichael AJ; Jones EY; Rowland-Jones SL
J Exp Med; 2004 Dec; 200(12):1547-57. PubMed ID: 15596521
[TBL] [Abstract][Full Text] [Related]
2. Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef.
Maurer K; Harrer EG; Goldwich A; Eismann K; Bergmann S; Schmitt-Haendle M; Spriewald B; Mueller SM; Harrer T;
J Acquir Immune Defic Syndr; 2008 Jun; 48(2):133-41. PubMed ID: 18391752
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
5. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
8. The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.
Ranasinghe SR; Kramer HB; Wright C; Kessler BM; di Gleria K; Zhang Y; Gillespie GM; Blais ME; Culshaw A; Pichulik T; Simmons A; Rowland-Jones SL; McMichael AJ; Dong T
PLoS Pathog; 2011 May; 7(5):e1001341. PubMed ID: 21589893
[TBL] [Abstract][Full Text] [Related]
9. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
da Silva J; Hughes AL
Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
[TBL] [Abstract][Full Text] [Related]
10. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
11. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.
Couillin I; Culmann-Penciolelli B; Gomard E; Choppin J; Levy JP; Guillet JG; Saragosti S
J Exp Med; 1994 Sep; 180(3):1129-34. PubMed ID: 7520468
[TBL] [Abstract][Full Text] [Related]
12. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
13. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.
Harrer EG; Bergmann S; Eismann K; Rittmaier M; Goldwich A; Müller SM; Spriewald BM; Harrer T
AIDS; 2005 Apr; 19(7):734-5. PubMed ID: 15821402
[TBL] [Abstract][Full Text] [Related]
14. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.
Yang OO; Nguyen PT; Kalams SA; Dorfman T; Göttlinger HG; Stewart S; Chen IS; Threlkeld S; Walker BD
J Virol; 2002 Feb; 76(4):1626-31. PubMed ID: 11799157
[TBL] [Abstract][Full Text] [Related]
15. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
16. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
[TBL] [Abstract][Full Text] [Related]
17. Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition.
Bauer M; Lucchiari-Hartz M; Maier R; Haas G; Autran B; Eichmann K; Frank R; Maier B; Meyerhans A
Immunol Lett; 1997 Feb; 55(2):119-22. PubMed ID: 9143944
[No Abstract] [Full Text] [Related]
18. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
19. Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.
Nixon DF; Douek D; Kuebler PJ; Jin X; Vesanen M; Bonhoeffer S; Cao Y; Koup RA; Ho DD; Markowitz M
Immunol Lett; 1999 Mar; 66(1-3):219-28. PubMed ID: 10203058
[TBL] [Abstract][Full Text] [Related]
20. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.
Spiegel HM; DeFalcon E; Ogg GS; Larsson M; Beadle TJ; Tao P; McMichael AJ; Bhardwaj N; O'Callaghan C; Cox WI; Krasinski K; Pollack H; Borkowsky W; Nixon DF
J Infect Dis; 1999 Aug; 180(2):359-68. PubMed ID: 10395850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
